TEAEs most frequently reported by subjects administered matching placebo included lymphocytopenia (100%), leukopenia (50.0%), elevated C-reactive protein (100%), neutropenia (50%), fever (100%), headache (100%), and myalgia (50%). The gene discussed is CRP; the disease is Decreased total neutrophil count.